Chemistry: analytical and immunological testing – Biospecific ligand binding assay
Patent
1998-01-21
1999-10-19
Tsang, Cecilia J.
Chemistry: analytical and immunological testing
Biospecific ligand binding assay
530324, 424538, G01N 33566
Patent
active
059688386
ABSTRACT:
The invention provides a novel peptide isolated from the venom of the spider Grammostola spatulata which peptide has antiarrhthymic activity. The invention also provides methods of treating arrhthymia comprising administering to a patient in need of such treatment an effective amount of the peptide. The invention further provides pharmaceutical compositions and methods of mediating hypotonic cell swelling induced calcium increase in cells.
REFERENCES:
patent: 4925664 (1990-05-01), Jackson et al.
patent: 5064657 (1991-11-01), Jackson et al.
patent: 5122596 (1992-06-01), Phillips et al.
patent: 5196204 (1993-03-01), Jackson et al.
patent: 5281693 (1994-01-01), Jackson et al.
Lampe et al., "Isolation and Pharmacological Characterization of .omega.-Grammotoxin SIA, a Novel Peptide Inhibitor of Neuronal Voltage-Sensitive Calcium Channel Responses", Molecular Pharmacology, 44:451-460, May 18, 1993.
Lampe Richard Alexander
Sachs Frederick
Borin Michael
Higgins Patrick H.
Hohenschutz Liza D.
Tsang Cecilia J.
Zeneca Limited
LandOfFree
Antiarrhythmic peptide from venom of spider Grammostola spatulat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiarrhythmic peptide from venom of spider Grammostola spatulat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiarrhythmic peptide from venom of spider Grammostola spatulat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2055000